Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase Cθ-deficient mice

Journal of Immunology

Volumn 176, Issue 5, 2006, Pages 2872-2879

  Tan, Seng Lai ^a   Zhao, Jingyong ^a   Bi, Chen ^a   Chen, Xinyi Cynthia ^a   Hepburn, Deena L ^a   Wang, Jian ^a   Sedgwick, Jonathon D ^a   Chintalacharuvu, Subba R ^a   Na, Songqing ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55]; PROTEIN KINASE C THETA; PROTEIN SERINE THREONINE KINASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DISEASE ACTIVITY; DISEASE COURSE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; UPREGULATION; WILD TYPE;

EID: 33644512418     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.5.2872     Document Type: Article

References (37)

1. Tseng, S. Y., and M. L. Dustin. 2002. T-cell activation: a multidimensional signaling network. Curr. Opin. Cell Biol. 14: 575-580.
2. Baier, G. 2003. The PKC gene module: molecular biosystematics to resolve its T cell functions. Immunol. Rev. 192: 64-79.
3. Arendt, C. W., B. Albrecht, T. J. Soos, and D. R. Littman. 2002. Protein kinase C-θ: signaling from the center of the T-cell synapse. Curr. Opin. Immunol. 14: 323-330.
4. Isakov, N., and A. Altman. 2002. Protein kinase Cθ in T cell activation. Annu. Rev. Immunol. 20: 761-794.
5. Baier-Bitterlich, G., F. Uberall, B. Bauer, F. Fresser, H. Wachter, H. Grunicke, G. Utermann, A. Altman, and G. Baier. 1996. Protein kinase C-θ isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol. Cell. Biol. 16: 1842-1850.
6. Lin, X., A. O'Mahony, Y. Mu, R. Geleziunas, and W. C. Greene. 2000. Protein kinase C-θ participates in NF-κB activation induced by CD3-CD28 costimulation through selective activation of IκB kinase β. Mol. Cell. Biol. 20: 2933-2940.
7. Coudronniere, N., M. Villalba, N. Englund, and A. Altman. 2000. NF-κB activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-θ. Proc. Natl. Acad. Sci. USA 97: 3394-3399.
8. Bauer, B., N. Krumbock, N. Ghaffari-Tabrizi, S. Kampfer, A. Villunger, M. Wilda, H. Hameister, G. Utermann, M. Leitges, F. Uberall, et al. 2000. T cell expressed PKCθ demonstrates cell-type selective function. Eur. J. Immunol. 30: 3645-3654.
9. Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, et al. 2000. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404: 402-407.
10. 2+ mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 197: 1525-1535.
11. Li, Y., J. Hu, R. Vita, B. Sun, H. Tabata, and A. Altman. 2004. SPAK kinase is a substrate and target of PKCθ in T-cell receptor-induced AP-1 activation pathway. EMBO J. 23: 1112-1122.
12. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
13. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
14. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182: 1579-1584.
15. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15: 297-322.
16. Dong, C., and R. A. Flavell. 2000. Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis Res. 2: 179-188.
17. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
18. Salek-Ardakani, S., T. So, B. S. Halteman, A. Altman, and M. Croft. 2004. Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase Cθ. J. Immunol. 173: 6440-6447.
19. Marsland, B. J., T. J. Soos, G. Spath, D. R. Littman, and M. Kopf. 2004. Protein kinase Cθ is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J. Exp. Med. 200: 181-189.
20. Owens, T., and S. Sriram. 1995. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 13: 51-73.
21. Mages, H. W., A. Hutloff, C. Heuck, K. Buchner, H. Himmelbauer, F. Oliveri, and R. A. Kroczek. 2000. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Euar. J. Immunol. 30: 1040-1047.
22. Berg-Brown, N. N., M. A. Gronski, R. G. Jones, A. R. Elford, E. K. Deenick, B. Odermatt, D. R. Littman, and P. S. Ohashi. 2004. PKCθ signals activation versus tolerance in vivo. J. Exp. Med. 199: 743-752.
23. + T cell effector and memory responses. Proc. Natl. Acad. Sci. USA 102: 14374-14379.
24. Giannoni, F., A. B. Lyon, M. D. Wareing, P. B. Dias, and S. R. Sarawar. 2005. Protein kinase Cθ is not essential for T-cell-mediated clearance of murine gammaherpesvirus 68. J. Virol. 79: 6808-6813.
25. Liu, X. K., X. Lin, and S. L. Gaffen. 2004. Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J. Biol. Chem. 279: 52762-52771.
26. Hogg, N., A. Smith, A., McDowall, K. Giles, P. Stanley, M. Laschinger, and R. Henderson. 2004. How T cells use LFA-1 to attach and migrate. Immunol. Lett. 92: 51-54.
27. Laschinger, M., P. Vajkoczy, and B. Engelhardt. 2002. Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur. J. Immunol. 32: 3598-3606.
28. 2 integrin LFA-1 in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55: 1060-1072.
29. Lou, J., M. Chofflon, C. Juillard, Y. Donati, N. Mili, C. A. Siegrist, and G. E. Grau. 1997. Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity. NeuroReport 8: 629-633.
30. Gordon, E. J., K. J. Myers, J. P. Dougherty, H. Rosen, and Y. Ron. 1995. Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 62: 153-160.
31. Willenborg, D. O., M. A. Staykova, and M. Miyasaka. 1996. Short-term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity. J. Immunol. 157: 1973-1980.
32. Muraro, P. A., L. Liberati, L. Bonanni, A. Pantalone, C. M. Caporale, C. Iarlori, G. De Luca, D. Farina, A. Lugaresi, and D. Gambi. 2004. Decreased integrin gene expression in patients with MS responding to interferon-β treatment. J. Neuroimmunol. 150: 123-131.
33. Stanislaus, R., A. K. Singh, and I. Singh. 2001. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J. Neurosci. Res. 66: 155-162.
34. Weitz-Schmidt, G., K. Welzenbach, V. Brinkmann, T. Kamata, J. Kallen, C. Bruns, S. Cottens, Y. Takada, and U. Hommel. 2001. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7: 687-692.
35. Bertolotto, C., L. Maulon, N. Filippa, G. Baier, and P. Auberger. 2000. Protein kinase Cθ and ε promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD. J. Biol. Chem. 275: 37246-37250.
36. Villalba, M., P. Bushway, and A. Altman. 2001. Protein kinase C-θ mediates a selective T cell survival signal via phosphorylation of BAD. J. Immunol. 166: 5955-5963.
37. Salek-Ardakani, S., T. So, B. S. Halteman, A. Altman, and M. Croft. 2005. Protein kinase Cθ controls Th1 cells in experimental autoimmune encephalomyelitis. J. Immunol. 175: 7635-7641.